Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.

Episode 58 November 05, 2021 01:27:22
Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.
MitoAction Expert Series
Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.

Nov 05 2021 | 01:27:22

/

Show Notes

Join MitoAction and Dr. Richard Boles for our November Mito Expert Series presentation titled: Whole genome sequencing with comprehensive re-analysis in undiagnosed or unclear causes with mitochondrial dysfunction: How this can lead to improved diagnosis, treatment, and clinical outcomes.

Dr. Boles will talk with us about the Neurabilities NeuroGenomics Program and how we can make exact diagnoses using whole genome sequencing, translate that into treatments, and improve clinical outcomes. He will also share information with us about the NeuroNeeds product line.

Click here for the accompanying slides.

Other Episodes

Episode 0

June 08, 2020 01:02:14
Episode Cover

DTC Testing - Power & Pitfalls - Dr. Fran Kendall - 4/5/19

Join MitoAction and Dr. Frank Kendall to discuss Direct to Consumer genetic testing (DTC testing) in detail. Some talking points will include: Strengths and...

Listen

Episode

August 18, 2022 01:02:07
Episode Cover

Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from...

Listen

Episode

April 13, 2022 00:18:20
Episode Cover

Teen Interview with Annalise - 10/16/2008

Teen Interview with Annalise

Listen